X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs PIRAMAL ENTERPRISES - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER PIRAMAL ENTERPRISES PFIZER/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 24.5 36.3 67.5% View Chart
P/BV x 3.9 3.6 107.7% View Chart
Dividend Yield % 0.8 0.7 123.8%  

Financials

 PFIZER   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    PFIZER
Mar-16
PIRAMAL ENTERPRISES
Mar-16
PFIZER/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs2,7241,065 255.8%   
Low Rs1,611805 200.1%   
Sales per share (Unadj.) Rs440.9383.0 115.1%  
Earnings per share (Unadj.) Rs48.755.1 88.4%  
Cash flow per share (Unadj.) Rs75.874.1 102.3%  
Dividends per share (Unadj.) Rs15.0017.50 85.7%  
Dividend yield (eoy) %0.71.9 37.0%  
Book value per share (Unadj.) Rs462.9719.9 64.3%  
Shares outstanding (eoy) m45.75172.56 26.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.92.4 201.4%   
Avg P/E ratio x44.517.0 262.3%  
P/CF ratio (eoy) x28.612.6 226.6%  
Price / Book Value ratio x4.71.3 360.5%  
Dividend payout %30.831.8 97.0%   
Avg Mkt Cap Rs m99,163161,344 61.5%   
No. of employees `0002.93.8 76.4%   
Total wages/salary Rs m2,75816,898 16.3%   
Avg. sales/employee Rs Th6,981.717,472.6 40.0%   
Avg. wages/employee Rs Th954.54,466.9 21.4%   
Avg. net profit/employee Rs Th771.12,512.8 30.7%   
INCOME DATA
Net Sales Rs m20,17066,099 30.5%  
Other income Rs m8572,425 35.4%   
Total revenues Rs m21,02868,524 30.7%   
Gross profit Rs m4,31018,723 23.0%  
Depreciation Rs m1,2393,274 37.8%   
Interest Rs m59,388 0.1%   
Profit before tax Rs m3,9238,485 46.2%   
Minority Interest Rs m03 0.0%   
Prior Period Items Rs m01,593 0.0%   
Extraordinary Inc (Exp) Rs m99457 21.6%   
Tax Rs m1,7941,032 173.9%   
Profit after tax Rs m2,2289,506 23.4%  
Gross profit margin %21.428.3 75.4%  
Effective tax rate %45.712.2 376.1%   
Net profit margin %11.014.4 76.8%  
BALANCE SHEET DATA
Current assets Rs m16,29947,488 34.3%   
Current liabilities Rs m7,594104,362 7.3%   
Net working cap to sales %43.2-86.0 -50.2%  
Current ratio x2.10.5 471.7%  
Inventory Days Days6541 160.7%  
Debtors Days Days2651 50.3%  
Net fixed assets Rs m8,62226,532 32.5%   
Share capital Rs m458345 132.6%   
"Free" reserves Rs m20,722114,024 18.2%   
Net worth Rs m21,180124,221 17.1%   
Long term debt Rs m2575,812 0.0%   
Total assets Rs m29,137308,356 9.4%  
Interest coverage x755.51.9 39,681.7%   
Debt to equity ratio x00.6 0.2%  
Sales to assets ratio x0.70.2 322.9%   
Return on assets %7.76.1 125.1%  
Return on equity %10.57.7 137.4%  
Return on capital %19.010.0 190.7%  
Exports to sales %0.117.2 0.3%   
Imports to sales %17.56.6 264.8%   
Exports (fob) Rs m1211,362 0.1%   
Imports (cif) Rs m3,5264,364 80.8%   
Fx inflow Rs m5214,435 0.4%   
Fx outflow Rs m1405,183 2.7%   
Net fx Rs m-889,253 -1.0%   
CASH FLOW
From Operations Rs m3,436-67,773 -5.1%  
From Investments Rs m-6,991-8,768 79.7%  
From Financial Activity Rs m-61976,199 -0.8%  
Net Cashflow Rs m-4,174-342 1,218.9%  

Share Holding

Indian Promoters % 0.0 52.9 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 4.0 187.5%  
FIIs % 4.9 26.6 18.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 16.5 143.6%  
Shareholders   85,207 93,274 91.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Recovery of Global Markets, Apex Frozen Food IPO & Cues to Watch Out Today(Pre-Open)

Indian stock markets remained range-bound in lacklustre trade on Tuesday as market participants kept to the sidelines in the absence of clear triggers.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Aug 23, 2017 09:39 AM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS